| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | US20060063702 Neuromedin U 2 receptor agonists and uses thereof |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063203 Vascular endothelial cell growth factor variants and uses thereof |
| 03/23/2006 | US20060062823 Microtubule stabilisers for treating stenosis in stents |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | DE102004045825A1 Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid Lyophilisate containing N-diaminomethylene-2-methyl-4,5-di (methylsulfonyl) benzamide |
| 03/23/2006 | DE102004045796A1 Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung Medicines containing carbonyl compounds and their use |
| 03/23/2006 | CA2620208A1 Methods and compositions for the treatment of hyperlipidemia |
| 03/23/2006 | CA2601996A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 03/23/2006 | CA2583410A1 Thyroid hormone analogs for promoting angiogenesis |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637589A1 Novel stem cell derived from adult tissue and use thereof |
| 03/22/2006 | EP1637539A1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637532A1 Fused pyrimidine derivative |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637519A1 Crystalline forms of the sodium salt of 5-chloro-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonylphenyl)ethyl)benzamide |
| 03/22/2006 | EP1637517A1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637161A1 REMEDY FOR CEREBRAL NEURODEGENERATIVE DISEASES USING PPAR&dgr; AGONIST |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637152A1 A notoginseng saponin intravenous injection and the method for preparing this injection |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1637136A1 Composition having autonomic nerve modulating activity and method of use thereof |
| 03/22/2006 | EP1637134A1 Composition for prevention/treatment for varicose veins |
| 03/22/2006 | EP1637133A2 Use of 2,5-dihydroxybenzenesulfonic acid derivatives for the preparation of medicaments for normalising the endothelial function, for the treatment of sexual dysfunction and vascular complications of diabetes, and vascular disorders of endothelial origin |
| 03/22/2006 | EP1637127A2 Generation of therapeutic microfoam |
| 03/22/2006 | EP1636365A1 Cholesterol biosynthesis pathway modulators and uses thereof |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636228A1 Novel pyridopyrazines and use thereof as kinase modulators |
| 03/22/2006 | EP1636224A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 03/22/2006 | EP1636221A2 New azetidine compounds |
| 03/22/2006 | EP1636198A1 Aniline derivatives |
| 03/22/2006 | EP1635877A2 Specific high-relaxivity conjugate compounds for magnetic resonance imaging |
| 03/22/2006 | EP1635838A2 Prophylaxis and/or treatment of portal hypertension |
| 03/22/2006 | EP1635816A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 03/22/2006 | EP1635805A2 Sigma ligands for neuronal regeneration and functional recovery |
| 03/22/2006 | EP1635801A2 Methods for treating and preventing cardiac arrhythmia |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1404301A4 Stable controlled release pharmaceutical compositions containing pravastatin |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1750838A Medical drug containing fine particle of noble metal |
| 03/22/2006 | CN1750832A Blood-vessel-growth promoter |
| 03/22/2006 | CN1750831A Therapeutic agent for hemorrhoidal disease |
| 03/22/2006 | CN1750830A Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention |
| 03/22/2006 | CN1750824A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 03/22/2006 | CN1750817A Use of the (1s, 2r) enantiomer of milnacipran for the preparation of a drug |
| 03/22/2006 | CN1749257A Platelet activation factor resisting compound |
| 03/22/2006 | CN1748805A Kit for applying drug coating to a medical device in surgeon room |
| 03/22/2006 | CN1748750A Medicinal wine for preventing and treating cardio-cerebral vascular diseases |
| 03/22/2006 | CN1748738A Chinese medicine cinnamon twig and poria dripping pill and its preparing method |
| 03/22/2006 | CN1748734A Pure Chinese medicinal preparation for treating angitis and its preparing method |
| 03/22/2006 | CN1748724A Medicine for treating cardio-cerebral vascular diseases and its preparing method |
| 03/22/2006 | CN1748722A Chinese medicine composition for treating cardio-cerebral vascular diseases and its preparing method and use |
| 03/22/2006 | CN1748718A Fresh earthworm preparation with the functions of calming the liver and relieving convulsion, promoting blood circulation and removing obstruction in channels and its preparing method |
| 03/22/2006 | CN1748706A Compositions of lecithin and flavonoid small molecule, preparing method and their use |
| 03/22/2006 | CN1748701A New method for producing pyritinol hydrochloride for injection |
| 03/22/2006 | CN1748676A Ligustilide oil and its preparation |
| 03/22/2006 | CN1748673A Medicinal composition and its use in preparing medicine for treating or preventing cardio-cerebral vascular diseases |
| 03/22/2006 | CN1748653A Medicament distribution device |
| 03/22/2006 | CN1246447C Method for making health wine from fritillary bulb |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246030C Medicine for treating cardio-cerebral vascular disease |
| 03/22/2006 | CN1246028C Medicine for treating fistulas and piles and anal fistula |
| 03/22/2006 | CN1246027C Medicine for treating high blood pressure and its preparation method |
| 03/22/2006 | CN1246026C Chinese medicine oral liquid and its application in pharmacy |
| 03/22/2006 | CN1246019C Chinese medicine preparation for curing angitis |
| 03/22/2006 | CN1246011C Use of lotus root joint extract in preparing medicine for improving human insulin resistance and preventing obesity |
| 03/22/2006 | CN1246006C Multifunction health therapeutic external use liquid |
| 03/22/2006 | CN1246002C Sichuan ginseng capsule and preparing process thereof |
| 03/22/2006 | CN1246000C Guangsheng hemp extract, its preparing method and use |